Century Therapeutics
IPSC
55 hedge funds and large institutions have $36.1M invested in Century Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 13 closing their positions.
133% more call options, than puts
Call options by funds: $7K | Put options by funds: $3K
2.16% less ownership
Funds ownership: 32.38% → 30.22% (-2.2%)
14% less funds holding
Funds holding: 64 → 55 (-9)
15% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 20
41% less capital invested
Capital invested by funds: $61M → $36.1M (-$24.8M)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$365K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$90.8K |
| 3 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$80.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$66.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.71M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$1.28M |
| 3 |
Millennium Management
New York
|
-$177K |
| 4 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$155K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$103K |
IPSC Hedge Fund Activity: Q3 2023 in Review
55 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q3 2023, worth a combined $36.1M — down 41% from $61M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of IPSC and 4 opened new positions — a net loss of 9 holders — while 20 trimmed existing stakes and 17 added.
The largest buyer was Morgan Stanley, adding an estimated $365K. The largest seller was Fidelity Investments, cutting an estimated $1.71M.
- 55 institutional investors held Century Therapeutics (IPSC) as of Q3 2023, down from 64 in Q2 2023.
- Funds reported $36.1M of Century Therapeutics stock for Q3 2023, down 41% quarter-over-quarter.
- 4 funds opened new Century Therapeutics positions in Q3 2023 and 13 closed out, a net change of -9 holders.
- The largest Century Therapeutics buyer in Q3 2023 was Morgan Stanley, an estimated $365K added.
- The largest Century Therapeutics seller in Q3 2023 was Fidelity Investments, an estimated $1.71M sold.
Based on aggregated 13F filings for Q3 2023.